The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Volume reached 3,152 shares, with price reaching a high of $238.38 and a low of $238.38. The stock was recently discussed on Yahoo Finance as it revealed that Dillard’s, Inc. Announces $0.20 Cash Dividend.
The company is listed on the NYSE and operates within the Department Stores industry segment. At the end of the last regular session, the stock closed at $238.38 and fluctuated between $242.03 as its day high and $234.60 as its day low. The current market capitalization of Dillard’s Inc. is $4.22B. A total of 0.12 million shares were traded on the day, compared to an average of 234.21K shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, DDS has seen 23 BUY and 2 SELL insider trades, representing the acquisition of 9,875 and the disposition of 1,800 shares. Over the last 12 months, there were 163 BUYs and 6 SELLs from insiders. Insiders purchased 63,777 shares during that period but sold 66,477.
In the most recent transaction, LITCHFORD MIKE sold 500 shares of DDS for 319.69 per share on Jun 03. After the transaction, the Vice President now owns 2,732 company shares. In a previous transaction on Apr 28, Rutledge Reynie bought 3 shares at 293.39 per share. DDS shares that Director owns now total 20,830.
Among the insiders who bought shares, STEPHENS WARREN A acquired of 20,000 shares on Feb 23 at a per-share price of $230.51. This resulted in the Director holding 94,668 shares of DDS after the transaction. In another insider transaction, Rutledge Reynie bought 3 shares at $265.04 per share on Jan 27. Company shares held by the Director now total 20,827.
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Dillard’s Inc. pays an annual dividend of $0.80, resulting in a dividend yield of 0.34%, and it has a price to earnings (P/E) ratio of 4.87. DDS’s most recent ex-dividend date was 06/29/2022 when it declared a $0.20 quarterly dividend that was paid in cash on 08/01/2022. Previously, the company paid the dividend on 05/02/2022 with an ex-dividend date of 03/30/2022. The dividend was $0.20 per share in cash.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for DDS in the last 3 months, the mean price target is $200.00 with high estimates of $325.00 and low estimates of $140.00. In terms of 52-week highs and lows, DDS has a high of $400.16 and a low of $156.92.
As of this writing, DDS has an earnings estimate of $2.88 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of $2.99 per share and a lower estimate of $2.77. The company reported an EPS of $13.37 in the last quarter, which was 149.44% higher than expectations of $5.36.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 5 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DDS is Overweight with a score of 2.00. A total of 0 analysts rated the stock as Buy while 1 rated it as Overweight while 1 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 2 thought it should be Sold.